Calidi Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $8.9M
Liabilities Breakdown FY2025
Total Liabilities: $5.1M
Asset Breakdown
Total Assets: $8.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.8M | 65.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $781.0K | 8.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.3M | 25.5% |
Liabilities Breakdown
Total Liabilities: $5.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $600.0K | 11.8% |
| Other Liabilities | $4.5M | 88.2% |